Latest news
Loading news…
Natrogen Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). New York, United States Founded 2002 1-10 employees For Profit
Natrogen Therapeutics develops Natura-alpha, a small molecule oral compound used in clinical trials for patients with ulcerative colitis.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Patents granted
- 1
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
Company Info
- Founded
- 2002
- Employees
- 1-10
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- HQ
- New York, United States
- Region
- Greater New York Area, East Coast, Northeastern US
- Closed
- Sep 1, 2015
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.6
- Trend (30d)
- -1.6
- Trend (90d)
- -0.3
Key People at Natrogen Therapeutics
President
CEO
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Natrogen Therapeutics
Loading news…
FAQs about Natrogen Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.